Revision as of 18:01, 20 July 2011 editLouisajb (talk | contribs)Extended confirmed users4,402 edits added chembl id← Previous edit |
Revision as of 07:19, 2 September 2011 edit undoBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBotNext edit → |
Line 1: |
Line 1: |
|
{{drugbox |
|
{{Drugbox |
|
⚫ |
| IUPAC_name = 4,5,6,7-tetrabromo-2-hydroxy-1,3,2-benzodioxabismole |
|
⚫ |
| image = Bibrocathol structure.svg |
|
|
|
|
|
<!--Clinical data--> |
|
|
| tradename = |
|
|
| Drugs.com = {{drugs.com|international|bibrocathol}} |
|
⚫ |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
|
⚫ |
| pregnancy_category = |
|
⚫ |
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
|
⚫ |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
⚫ |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
|
⚫ |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
⚫ |
| legal_status = |
|
⚫ |
| routes_of_administration = Topical (eye ointment) |
|
|
|
|
|
<!--Pharmacokinetic data--> |
|
⚫ |
| bioavailability = |
|
⚫ |
| protein_bound = |
|
⚫ |
| metabolism = |
|
⚫ |
| elimination_half-life = |
|
⚫ |
| excretion = |
|
|
|
|
|
<!--Identifiers--> |
|
⚫ |
| CAS_number = 6915-57-7 |
|
⚫ |
| ATC_prefix = S01 |
|
⚫ |
| ATC_suffix = AX05 |
|
⚫ |
| PubChem = 16683103 |
|
⚫ |
| DrugBank = |
|
⚫ |
| ChemSpiderID = 11232581 |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII = 0KJ20H1BLJ |
|
| UNII = 0KJ20H1BLJ |
|
⚫ |
| ChEMBL = 44875 |
⚫ |
| IUPAC_name = 4,5,6,7-tetrabromo-2-hydroxy-1,3,2-benzodioxabismole |
|
|
|
|
⚫ |
| image = Bibrocathol structure.svg |
|
|
|
<!--Chemical data--> |
|
⚫ |
| chemical_formula = |
|
⚫ |
| C=6 | H=1 | Bi=1 | Br=4 | O=3 |
|
⚫ |
| molecular_weight = 650.675 g/mol |
|
⚫ |
| smiles = O1Oc2c(Br)c(Br)c(Br)c(Br)c2O1 |
|
| InChI = 1/C6H2Br4O2.Bi.H2O/c7-1-2(8)4(10)6(12)5(11)3(1)9;;/h11-12H;;1H2/q;+3;/p-3/rC6HBiBr4O3/c8-1-2(9)4(11)6-5(3(1)10)13-7(12)14-6/h12H |
|
| InChI = 1/C6H2Br4O2.Bi.H2O/c7-1-2(8)4(10)6(12)5(11)3(1)9;;/h11-12H;;1H2/q;+3;/p-3/rC6HBiBr4O3/c8-1-2(9)4(11)6-5(3(1)10)13-7(12)14-6/h12H |
|
| InChIKey = VTAVFIZOZUAKKE-AJXSUKGNAS |
|
| InChIKey = VTAVFIZOZUAKKE-AJXSUKGNAS |
|
⚫ |
| synonyms = Bibrocathin<br>Tetrabromopyrocatechol bismuth |
⚫ |
| CAS_number = 6915-57-7 |
|
⚫ |
| ATC_prefix = S01 |
|
⚫ |
| ATC_suffix = AX05 |
|
⚫ |
| PubChem = 16683103 |
|
⚫ |
| DrugBank = |
|
⚫ |
| ChemSpiderID = 11232581 |
|
⚫ |
| ChEMBL = 44875 |
|
⚫ |
| chemical_formula = |
|
⚫ |
| C=6 | H=1 | Bi=1 | Br=4 | O=3 |
|
⚫ |
| molecular_weight = 650.675 g/mol |
|
⚫ |
| smiles = O1Oc2c(Br)c(Br)c(Br)c(Br)c2O1 |
|
⚫ |
| synonyms = Bibrocathin<br>Tetrabromopyrocatechol bismuth |
|
⚫ |
| bioavailability = |
|
⚫ |
| protein_bound = |
|
⚫ |
| metabolism = |
|
⚫ |
| elimination_half-life = |
|
⚫ |
| excretion = |
|
⚫ |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
|
⚫ |
| pregnancy_category= |
|
⚫ |
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
|
⚫ |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
⚫ |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
|
⚫ |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
⚫ |
| legal_status = |
|
⚫ |
| routes_of_administration = Topical (eye ointment) |
|
|
}} |
|
}} |
|
'''Bibrocathol''' (], trade names '''Noviform''' and '''Posiformin''') is the substance 4,5,6,7-Tetrabrom-1,3,2-benzodioxabismol-2-ol. It contains ] and is used to treat eye infections and control swelling. |
|
'''Bibrocathol''' (], trade names '''Noviform''' and '''Posiformin''') is the substance 4,5,6,7-Tetrabrom-1,3,2-benzodioxabismol-2-ol. It contains ] and is used to treat eye infections and control swelling. |